Portfolio
Strategy
Team
News
Careers
Contact
Investor Login
Portfolio
Strategy
Team
News
Careers
Contact
Cidara Therapeutics Reacquires Global Development and Commercial Rights to CD388 and Announces Private Placement Financing of $240 Million
Read Article
News
2024
2023
Archive
Search news articles
November 9, 2020
Impel Neuropharma Announces FDA Submission of New Drug Application for INP104 for the Acute Treatment of Migraine
November 9, 2020
Homology Medicines Announces $60 Million Equity Investment from Pfizer Inc.
November 6, 2020
Artiva & Affimed Announce Platform-to-Platform R&D Collaboration for Off-the-Shelf NK Cell Therapies
November 6, 2020
Pear Therapeutics Announces Publication of Real-World Data Demonstrating Impact of reSET-O® for Patients with Opioid Use Disorder
November 6, 2020
Pear Therapeutics Announces Publication of Real-World Healthcare Resource Utilization Data for reSET-O®
November 6, 2020
Homology Medicines Announces Presentation of Positive Data from the Dose-Escalation Phase of the pheNIX Gene Therapy Trial for Adults with PKU
November 5, 2020
Homology Medicines Announces Upcoming Oral Presentation on pheNIX Gene Therapy Clinical Trial for Adults with PKU
November 2, 2020
Rallybio Appoints Paula Soteropoulos to Board of Directors
November 2, 2020
Pear Therapeutics Wins Prix Galien USA Award for Somryst™ as Best Digital Health Product
October 23, 2020
Canada’s Prime Minister, Justin Trudeau, Announced Today Precision NanoSystems Will Receive $18.2 Million from the Government of Canada to Develop an RNA Vaccine for COVID-19
« Previous Page
1
…
48
49
50
51
52
…
119
Next Page »